Burning Rock Biotech Ltd. ADR (BNR) Social Stream



Burning Rock Biotech Ltd. ADR (BNR): $3.69

-0.27 (-6.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Burning Rock Biotech Ltd (BNR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BNR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-25 3 $36.1 $27.5 $31.8 $10.3 208.74%
2021-12-06 3 $36.1 $23 $29.55 $10.3 186.89%
2022-01-06 3 $26.7 $23 $24.85 $10.3 141.26%
2022-03-17 3 $26.7 $13.5 $20.1 $10.3 95.15%
2022-03-23 3 $26.7 $13 $19.85 $10.3 92.72%
2022-03-25 3 $13 $12.8 $12.9 $10.3 25.24%

The Trend in the Analyst Price Target


BNR's average price target has moved down $19.2 over the prior 16 months.

Over the past 151 days, BNR's average upside potential has been 120.39%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-25 3 36.1 27.5 31.80 14.04 126.5%
2022-01-06 3 26.7 23.0 24.85 9.38 164.93%
2022-03-17 3 36.1 13.5 24.80 9.01 175.25%
2022-03-23 3 26.7 13.0 19.85 9.59 106.99%
2022-03-25 3 13.0 12.8 12.90 9.43 36.8%

BNR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


BNR's average broker recommendation rating improved by 0 over the prior 16 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Burning Rock Biotech Ltd's number of analysts covering the stock is greater than 77.98% of them.
  • In terms of how Burning Rock Biotech Ltd fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 555.08% of that group.
  • In terms of how Burning Rock Biotech Ltd fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -262.16% of that group.
  • In terms of how Burning Rock Biotech Ltd fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 180.06% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to Burning Rock Biotech Ltd are SMFR, SHCR, and PRVA.

What is the outlook for BNR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5067 seconds.